Massive data analysis advances understanding of how immunotherapy works
What factors influence the success or failure of immunotherapy treatment in patients with advanced bladder cancer? Why do ...
BESREMi Achieves Strong Market Growth Amid Rising Demand for Polycythemia Vera Treatment
BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESREMi faces competition from drugs like ruxolitinib, a ...
Analytics India Magazine18 小时
NVIDIA and Arc Institute Unveil an AI Model to Predict DNA, RNA & Proteins
California-based nonprofit Arc Institute and Stanford University, in collaboration with NVIDIA, unveiled Evo 2 on Wednesday ...